Abstract
Antibody-based detection systems for specific Ags are versatile and powerful tools for various molecular and cellular analyses, as well as clinical diagnostics. The power of such systems originates from the considerable specificity of Abs for particular antigenic epitopes. There are, however, numerous examples where important biological markers for cancer, infectious disease, or biochemical processes are present at too low a concentration in body fluids or tissues to be detected by using conventional immunoassays.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alcorn, S.W., Pascho, R.J., 2000, Single-dilution enzyme-linked immunosorbent assay for quantification of antigen-specific salmonid antibody. J Vet Diagn Invest 12(3):245–252.
Arenkov, P., Kukhtin, A., Gemmelll, A., Voloshchuck, S., Chupeeva, V., Mirzabekov, A., 2000, Protein microchips: use for immunoassay and enzymatic reactions. Ana Biochem 278(2):123–131
Beqai, S.H., Lerner, A.M., Fitzgerald, J.T., 2008, Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol 61(5):623–626.
Bosch, A.M.G., Van Hell, H., Brands, J.A.M., Dijkhuizen, D.M., Schuurs, A.H.W.M., 1975, Methods for the determination of total estrogens (TE) and human placental lactogen (HPL) in plasma of pregnant women by enzyme-immunoassay. Clin Chem 21:1009.
Bourdage, J.S., Lee, T.N., Taylor, J.M., Willey, M.B., Brandt, J.T., Konrad, R.J., 2005, Effect of double antigen bridging immunoassay format on antigen coating concentration dependence and implications for designing immunogenicity assays for monoclonal antibodies. J Pharm Biomed Anal 39(3–4):685–690.
Catt, K., Tregear, G.W., 1967, Solid-phase radioimmunoassay in antibody-coated tubes. Science 158:1570–1572.
Edelman, R., 2007, Dengue vaccines approach the finish line. Clin Infect Dis 45 Suppl 1:S56–S60.
Engvall, E., Jonsson, K., Perlmann, P., 1971, Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes. Biochim Biophys Acta 251(3):427–434.
Engvall, E., Perlmann, P., 1971, Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8:871–874.
Engvall, E., Wewer, U.M., 2003 The new frontier in muscular dystrophy research: booster genes. FASEB J;17:1579–1584.
Findlay, J.W., Smith, W.C., Lee, J.W., Nordblom, G.D., Das, I., DeSilva, B.S., Khan, M.N., Bowsher, R.R., 2000, Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective J Pharm Biomed Anal 21(6):1249–1273.
Geng, D., Shankar, G., Schantz, A., Rajadhyaksha, M., Davis, H., Wagner, C., 2005, Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies. J Pharm Biomed Anal 39(3–4):364–375.
Grunow, R., Porsch-Ozchrumez, M., Splettstoesser, W., Buckendahl, A., Hahn, U., Beyer, W., Bohm, R., Huber, M., Vd Esche, U., Bessler, W., Frangoulidis, D., Finke, E.J., 2007, Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralizing antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine 25(18):3679–3683.
Halperin, G., Marcus, H., 2001, Application of recovery tests in the validation of immunoassays for assessing the immunogenicity of B. anthracis PA vaccine. PDA J Pharm Sci Technol 55(3):150–161.
Hashemitabar, G.R., Razmi, G.R., Shahroozian, A., 2008, Application of a modified human enzyme-linked immunosorbent assay kit for diagnosis of hydatidosis in sheep Iranian J Vet Res 9(1) serial no. 22:31–35.
Hix, J., Martinez, C., Buchanan, I., Morgan, J., Tam, M., Shankar, A., 2004, Development of a rapid enzyme immunoassay for the detection of retinol-binding protein. Am J Clin Nutrition 79(1):93–98.
Howell, E.E., Nasser, J., Schray, K.J., 1981, Coated tube enzyme immunoassay: factors affecting sensitivity and effects of reversible protein binding to polystyrene. J Immunoassay 2(3–4):205–225.
Hunsperger, E.A., Yoksan, S., Buchy, P., Nguyen, V.C., Sekaran, S.D., Enria, D.A., Pelegrino, J.L., Vazquez, S., Artsob, H., Drebot, M., et al., 2009, Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis 15(3):436–440.
Kolb, S.J., Gubitz, A.K., Olszewski, R.F., Jr., Ottinger, E., Sumner, C.J., Fischbeck, K.H., Dreyfuss, G., 2006, A novel cell immunoassay to measure survival of motor neurons protein in blood cells. BMC Neurol 6:6.
Liu, X., Dai, Q., Austin, L., Coutts, J., Knowles, G., Zou, J., Chen, H., Huo, Q., 2008, A one-step homogeneous immunoassay for cancer biomarker detection using glod nanoparticle probes coupled with dynamic light scattering. J Am Chem Soc 130(9):2780–2782.
Ludert, J.E., Mosso, C., Ceballos-Olvera, I., del Angel, R.M., 2008, Use of a commercial enzyme immunoassay to monitor dengue virus replication in cultured cells. Virol J 5:51.
Mida, T., Miyazaki, O., Nakamura, Y., Hirayama, S., Hanyu, O., Fukamachi, I., Okada, M., 2003, Analytical performance of a sandwich enzyme immunoassay for preβ-HDL in stabilized plasma. J Lipid Res 44(3):645–650.
Mire-Sluis, A.R., Barrett, Y.C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., Swanson, S.J., Taniguchi, G., Wierda, D., Zuckerman, L.A., 2004, Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J Immunol Methods 289(1–2):1–16.
Munial, S., Miethe, P., Netuschil, L., Struck, F., Maier, K., Bauermeister, C., 2007, Immunoassay-based diagnostic point-of-care technology for oral specimen. Ann N Y Acad Sci 1098:486–489.
Ong, C.S., Li, A.S., Priest, J.W., Copes, R., Khan, M., Fyfe, M.W., Marion, S.A., Roberts, J.M., Lammie, P.J., Isaac-Renton, J.L., 2005, Enzyme immunoassay of cryptosporidium-specific immunoglobulin G antibodies to assess longitudinal infection trends in six communities in British Columbia, Canada. Am J Trop Med Hyg 73(2):288–295.
Pombo, M., Berthold, I., Gingrich, E., Jaramillo, K., Leef, M., Sirota, L., Hsu, H., Arciniega, J., 2004, Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice. Biologicals 32(3):157–163.
Rubina, A.Y., Dyukova, V.I., Dementieva, E.I., Stomakhin, A.A., Nesmeyanov, V.A., Grishin, E.V., Zasedateley, A.S., 2005, Quantitative immunoassay of biotoxins on hydrogel-based protein m microchips. Anal Biochem 340(2):317–329.
Rucker, V.C., Havenstrite, K.L., Herr, A.E., 2005, Antibody microarrays for native toxin detection. Anal Biochem 339(2):262–270.
Schuurs, A.H.W.M., Van Weemen, B.K., 1980, Enzyme-immunoassay: a powerful analytical tool [Review]. J Immunoassay 1:229–249.
Schweitzer, B., Wiltshire, S., Lamber, J., O’Malley, S., Kukanskis, K., Zhu, Z., Kingsmore, S.F., Lizardi, P.M., Ward, D.C., 2000, Immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc Natl Acad Sci USA 97(18):10113–10119.
Seppala, M., Rutanen, E.M., Heikinheimo, M., Jalanko, H., Engvall, E., 1978 Detection of trophoblastic tumour activity by pregnancy-specific ß1 glycoprotein. Int J Cancer 21:265–267.
Sipponen, P., Ruoslahti, E., Vuento, M., Engvall, E., Stenman, U., Ihamakit, T., Suirala, M., 1976, CEA and CEA-like activity in gastric cancer. Acta Hepatogastroenterol (Stuttg) 13:276–279.
Takashi, M., Miyazaki, O., Nakamura, Y., et al., 2003, Analytical performance of a sandwich enzyme immunoassay for preß1-HDL in stabilized plasma, J Lipid Res 44:645–650.
Uotila, M., Ruoslathi, E., Engvall, E., 1981, Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alphafetoprotein. J Immunol Methods 42(1):11–15.
Valdes, I., Hermida, L., Martin, J., Menendez, T., Gil, L., Lazo, L., Castro, J, Niebla, O., Lopez C., Bernardo, L., Sanchez, J., Romero, Y., Martinez, R., Guzman, M.G., Guillen, G., 2009, Immunological evaluation in nonhuman primates of formulations based on the chimeric protein p64k-domain III of dengue 2 and two components of Neisseria meningitis. Vaccine 27(7):995–1001.
Van Cleave, V.H., 2003, Vailidation of immunoassays for anti-drug antibodies. Dev Biol (Basel) 112:107–112.
Van Weemen, B.K., Schuurs, A.H.W.M., 1974, Immunoassay using antibody-enzyme conjugates. FEBS Lett 43:215–218.
Von der Waat, M., Snelting, A., Cichy, J., Wolters, G., Schuurs, A., Schuurs, A.H.W.M., 1978, Enzyme immunoassay in diagnosis of hepatitis with emphasis on the detection of “e” antigen (HbeAg). J Med Virol 3(1):43–49.
Watt, R.M., Philip, A., Wos, S.M., Sam, G.J., 1986, Rapid assay for immunological detection of Trichomonas vaginalis. J Clin Microbiol 24(4):551–555.
Wolters, G., Kuijpers, L.P.C., Kacaki, J., Schuurs, A.H.W.M., 1976, Enzyme-immunoassay for HbsAg. Lancet II:690.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Debnath, M., Prasad, G.B., Bisen, P.S. (2010). Immunoassay. In: Molecular Diagnostics: Promises and Possibilities. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3261-4_11
Download citation
DOI: https://doi.org/10.1007/978-90-481-3261-4_11
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3260-7
Online ISBN: 978-90-481-3261-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)